Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
Hep C quad regimens quashed, but some components go forward
Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care
A majority of HIV-positive gay men in Dutch survey take their viral load into consideration if having unprotected sex
Researchers stop the only current HIV vaccine efficacy trial
AbbVie interferon-free combination cures over 90% of hepatitis C genotype 1
Sofosbuvir + ribavirin cures most genotype 2 hepatitis C, but genotype 3 response is lower
